Skip to main content
MED logo

MED · Medifast Inc

Track MED — free
$11.44 -0.04 (-0.35%) At close · Aug 14
Market Cap
$127.91M
Shares
11.18M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2023
Executive Total
Daniel R. Chard $7,039,062
James Maloney $2,009,824
Nicholas M. Johnson $1,703,445
Jason L. Groves $1,632,143
Anthony Tyree $1,608,190
Fiscal 2022
Executive Total
Daniel R. Chard $5,940,235
James Maloney $1,426,483
Nicholas M. Johnson $1,200,009
Jason L. Groves $1,158,643
Anthony Tyree $1,131,449
Fiscal 2021
Executive Total
Daniel R. Chard $6,565,494
James Maloney $1,621,243
Nicholas M. Johnson $1,418,746
Lauren Walker $1,385,783
Anthony Tyree $1,316,475
Fiscal 2020
Executive Total
Daniel R. Chard $5,539,836
Anthony Tyree $1,296,277
Nicholas M. Johnson $1,164,192
James Maloney $960,289
Fiscal 2019
Executive Total
Daniel R. Chard $4,669,993
Timothy G. Robinson $1,252,820
Anthony Tyree $1,056,028
Nicholas M. Johnson $703,875
Fiscal 2018
Executive Total
Daniel R. Chard $2,218,375
Nicholas M. Johnson $1,300,990
Timothy G. Robinson $1,066,642
Anthony Tyree
Fiscal 2017
Executive Total
Daniel R. Chard $1,622,197
Timothy G. Robinson $1,455,283
Nicholas M. Johnson
Anthony Tyree

Executive changes

Person Change Filed
Jason L. Groves, Esq. Resigned 2026-06-01
Nicholas Johnson Appointed 2026-05-26
Daniel Chard Appointed 2026-01-05
Nicholas Johnson Appointed 2026-01-05
Lauren Walker Retired 2023-04-20
Key facts CIK 910329 CUSIP 58470H101 13F (30d) 109 filings 107 filers Visit website Investor relations